Perspective on the future of drug development Webinar

Business and social imperatives are forcing changes in the strategies used in drug development. High throughput screening is delivering more candidate compounds. Many diseases now being targeted have complex pathways and are likely to require combinations of compounds, tailored to an individual’s biology, for effective treatment. Development costs are spiralling. There is an increased societal concern over the safety of new drugs. Pharmaceutical companies patented drugs are not being replaced as quickly as the patents are expiring. Webinar now available for on-demand viewing